Drug Shortage Report for DANTRIUM CAPSULES
| Report ID | 215589 |
| Drug Identification Number | 01997602 |
| Brand name | DANTRIUM CAPSULES |
| Common or Proper name | DANTROLENE SODIUM |
| Company Name | ENDO PAR INNOVATION COMPANY, LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | DANTROLENE SODIUM |
| Strength(s) | 25MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 Capsules |
| ATC code | M03CA |
| ATC description | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2023-12-15 |
| Actual start date | |
| Estimated end date | 2024-01-31 |
| Actual end date | 2024-02-01 |
| Shortage status | Resolved |
| Updated date | 2024-02-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6 RAM RIDGE ROAD CHESTNUT RIDGE, NEW YORK UNITED STATES 10977 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-02-07 | French | Compare |
| v3 | 2024-02-07 | English | Compare |
| v2 | 2024-01-11 | French | Compare |
| v1 | 2024-01-11 | English | Compare |
Showing 1 to 4 of 4